To test this hypothesis, a two-stage genetic association study was conducted that systematically evaluated 134 SNPs in these genes among 457 patients with prostate cancer who experienced BCR and then validated our findings in an independent cohort of 187 patients. The gene discussed is BCR; the disease is prostate carcinoma.